- |||||||||| Enrollment open: Home Treatment for Acute Psychiatric Care (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=500, Recruiting, Trial primary completion date: Dec 2016 --> Jun 2017 Not yet recruiting --> Recruiting
- |||||||||| Trial primary completion date: Healthy Bodies, Healthy Kids (clinicaltrials.gov) - Mar 24, 2016
P=N/A, N=126, Recruiting, Trial primary completion date: Jan 2016 --> Jun 2016 Trial primary completion date: Oct 2015 --> Dec 2016
- |||||||||| Enrollment closed, Trial primary completion date: The Partners Genetics Collaborative Study of Schizophrenia (clinicaltrials.gov) - Mar 19, 2016
P=N/A, N=500, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Oct 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Oct 2016
- |||||||||| Kuvan (sapropterin) / Merck (MSD), BioMarin, Daiichi Sankyo
Trial primary completion date: Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) - Mar 19, 2016 P1/2, N=60, Suspended, Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: Feb 2016 --> Jun 2016
- |||||||||| olanzapine / Generic mfg., sertraline / Generic mfg.
Trial primary completion date: STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) - Mar 19, 2016 P4, N=392, Recruiting, Trial primary completion date: Feb 2016 --> Jun 2016 Trial primary completion date: Mar 2017 --> Aug 2017
- |||||||||| carbidopa/levodopa / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Mar 15, 2016 P2, N=13, Completed, Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Completed | N=24 --> 13 | Trial primary completion date: Sep 2016 --> Dec 2015
- |||||||||| Trial completion, Trial primary completion date: Mental Health Engagement Network (MHEN) (clinicaltrials.gov) - Mar 8, 2016
P=N/A, N=400, Completed, Active, not recruiting --> Completed Not yet recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014
- |||||||||| Trial completion, Enrollment change: Oxytocin as Adjunctive Therapy for Schizophrenia (clinicaltrials.gov) - Feb 24, 2016
P2, N=32, Completed, Trial primary completion date: Dec 2014 --> Mar 2016 Active, not recruiting --> Completed | N=80 --> 32
- |||||||||| aripiprazole / Generic mfg., olanzapine / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date, Adverse events: Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic (clinicaltrials.gov) - Feb 10, 2016 P4, N=200, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Jan 2013 --> Jan 2015 Recruiting --> Active, not recruiting | N=340 --> 200 | Trial primary completion date: Dec 2015 --> May 2016
- |||||||||| Trial completion, Trial primary completion date: Illness Management and Recovery (IMR) in Danish Community Mental Health Centres (clinicaltrials.gov) - Feb 10, 2016
P=N/A, N=198, Completed, Recruiting --> Active, not recruiting | N=340 --> 200 | Trial primary completion date: Dec 2015 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2013
|